Results 41 to 50 of about 11,421 (234)

Alterations in brain network connectivity and subjective experience induced by psychedelics: a scoping review

open access: yesFrontiers in Psychiatry
Intense interest surrounds current research on psychedelics, particularly regarding their potential in treating mental health disorders. Various studies suggest a link between the subjective effects produced by psychedelics and their therapeutic efficacy.
Zijia Yu   +20 more
doaj   +1 more source

Psilocybin during the postpartum period induces long-lasting adverse effects in both mothers and offspring

open access: yesNature Communications
Psilocybin increases social connectedness and has strong clinical transdiagnostic efficacy for mental illness, making it a candidate treatment to reduce maternal disconnect, anxiety, and blunted affect seen in peripartum mood disorders.
Cassandra J. Hatzipantelis   +15 more
doaj   +1 more source

Cannabis-based extract for managing pain in dogs with osteoarthritis: efficacy and safety assessment

open access: yesFrontiers in Pharmacology
IntroductionCanine osteoarthritis (OA) is a prevalent disease characterized by progressive joint degeneration, pain, and impaired mobility. In older dogs, OA affects approximately 80% of the population.
Neide Maria Griebeler   +12 more
doaj   +1 more source

An ETH‐LAD trip with unfavourable consequences: A case report

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Numerous analogues of the psychedelic and internationally controlled hallucinogen LSD have been described; however, only a limited number have been systematically investigated. This report presents the first case with an analytically confirmed ingestion of ETH‐LAD (6‐ethyl‐6‐nor‐lysergic acid diethylamide), the N‐ethyl derivative of LSD.
Johannes Nadler   +6 more
wiley   +1 more source

Do Psychedelics Change Beliefs?

open access: yes, 2021
Renewed interest in psychedelics has reignited the debate about whether and how they change human beliefs. In both the clinical and social-cognitive domains, psychedelic consumption may be accompanied by profound, and sometimes lasting, belief changes ...
Brendan Hutchinson   +3 more
core   +1 more source

Pharmacokinetics and safety of a modified‐release psilocybin formulation: A SAD Phase I trial in normal‐weight and overweight/obese participants

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to evaluate the safety, tolerability and pharmacokinetics of a novel oral modified‐release psilocybin formulation (REL‐P11) in normal‐weight and overweight/obese healthy adults and to assess its suitability for controlled, subperceptual exposure, in light of emerging evidence supporting serotonergic modulation in metabolic ...
Anna Signor   +11 more
wiley   +1 more source

Psychedelics as change agents in addiction and mood disorders. [PDF]

open access: yes, 2017
Research on psychedelics has generated renewed interest over the past decade. Recent pilot studies have shown safety and feasibility of psilocybin, a naturally occurring psychedelic, as a therapeutic tool for treating mood and substance use disorders ...
Garcia-Romeu, Albert
core  

Localizing value of ecstatic phenomenon in epilepsy surgery: A systematic review

open access: yesEpileptic Disorders, EarlyView.
Abstract Objective A systematic review was conducted to synthesize current anatomo‐clinical correlations of ecstatic symptoms in focal epilepsy, aiming to provide evidence‐based guidance for interpreting this ictal semiology during presurgical evaluation.
Mihai Dragos Maliia   +2 more
wiley   +1 more source

Psychedelic Assisted Psychotherapy for Treating Substance Use Disorders

open access: yes, 2023
openDespite the rapid growth in the field of mental health, therapists still have relatively limited options when it comes to treating mental disorders. A promising field of study in recent years has been the research conducted on psychedelics.
OZERDEM, DENIZ BORA
core  

Home - About - Disclaimer - Privacy